The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Liver transplantation for hepatocellular carcinoma: Comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria
Abstract
We previously proposed modified staging criteria for predicting acceptable outcome after orthotopic liver transplantation (OLT) for hepatocellular carcinoma (HCC). These were solitary tumor ≤6.5 cm, or three or fewer nodules with the largest lesion ≤4.5 cm and total tumor diameter ≤8 cm, without gross vascular invasion (University of California, San Francisco [UCSF] criteria). In this study, we further evaluated the performance of the Milan criteria (solitary tumor ≤5 cm, or three or fewer lesions none >3 cm), the UCSF criteria, and the Pittsburgh modified tumor-node-metastasis (TNM) criteria. Pathologic HCC staging according to each set of criteria was performed in 70 patients. The difference in survival when comparing 24 patients with HCC exceeding Milan criteria versus 46 patients meeting Milan criteria did not reach statistical significance (HR, 2.0; P = .12). Using our definition for acceptable 2-year survival to be ≥70%, the 14 patients (20%) meeting UCSF criteria but exceeding Milan criteria had a 2-year survival of 86% (95% CI, 54% to 96%). Survival for Pittsburgh stage I, II, and IIIA patients as a group was significantly better than for stages IIIB and IVA patients combined (HR, 4.2; P = .007), and similar to survival for patients meeting UCSF criteria. Advanced tumor exceeding UCSF criteria served reasonably well as a surrogate marker for poorly differentiated grade and microvascular invasion. In conclusion, our analyses suggest that UCSF criteria better predict acceptable posttransplant outcome than Milan criteria. UCSF criteria confer a different advantage over Pittsburgh criteria, which require information on microvascular invasion that is difficult to ascertain preoperatively without the attendant risk of biopsy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transection of the oesophagus for bleeding oesophageal varices
Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., & Williams, R. (1973) · Journal of British Surgery · doi:10.1002/bjs.1800600817 · Cited by 7,941
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Primary carcinoma of the liver.A study of 100 cases among 48,900 necropsies
Edmondson, H. A., & Steiner, P. E. (1954) · Cancer · doi:10.1002/1097-0142(195405)7:3<462::aid-cncr2820070308>3.0.co;2-e · Cited by 2,772
Yao, F. Y., Ferrell, L., Bass, N. M., Watson, J. J., Bacchetti, P., Venook, A., Ascher, N. L., & Roberts, J. P. (2001) · Hepatology · doi:10.1053/jhep.2001.24563 · Cited by 2,262
Self-citationThe Statistical Analysis of Failure Time Data
Klein, J. P. (1982) · Technometrics · doi:10.1080/00401706.1982.10487769 · Cited by 2,215
The statistical analysis of failure time data
Herson, J. (1981) · Controlled Clinical Trials · doi:10.1016/0197-2456(81)90009-x · Cited by 1,380
TNM classification of malignant tumours
Cassoni, A. M. (1998) · Clinical Oncology · doi:10.1016/s0936-6555(98)80120-9 · Cited by 1,191
Prognostic prediction and treatment strategy in hepatocellular carcinoma
Bruix, J., & Llovet, J. M. (2002) · Hepatology · doi:10.1053/jhep.2002.32089 · Cited by 1,099
Jonas, S., Bechstein, W. O., Steinmüller, T., Herrmann, M., Radke, C., Berg, T., Settmacher, U., & Neuhaus, P. (2001) · Hepatology · doi:10.1053/jhep.2001.23561 · Cited by 894
Liver Resection Versus Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients
Bismuth, H., Chiche, L., Adam, R., Castaing, D., Diamond, T., & Dennison, A. (1993) · Annals of Surgery · doi:10.1097/00000658-199308000-00005 · Cited by 865
Cited by
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Yang, J. D., Hainaut, P., Gores, G. J., Amadou, A., Plymoth, A., & Roberts, L. R. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0186-y · Cited by 4,228
Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma
Maluccio, M., & Covey, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21161 · Cited by 840
Mazzaferro, V., Bhoori, S., Sposito, C., Bongini, M., Langer, M., Miceli, R., & Mariani, L. (2011) · Liver Transplantation · doi:10.1002/lt.22365 · Cited by 593
Yao, F. Y., Xiao, L., Bass, N. M., Kerlan, R., Ascher, N. L., & Roberts, J. P. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01965.x · Cited by 562
Self-citationSilva, M. A., Hegab, B., Hyde, C., Guo, B., Buckels, J. A. C., & Mirza, D. F. (2008) · Gut · doi:10.1136/gut.2008.149062 · Cited by 536
Liver Transplantation for Hepatocellular Carcinoma: Hangzhou Experiences [RETRACTED]
Zheng, S.-S., Xu, X., Wu, J., Chen, J., Wang, W.-L., Zhang, M., Liang, T.-B., & Wu, L.-M. (2008) · Transplantation · doi:10.1097/tp.0b013e31816b67e4 · Cited by 452
RetractedDuffy, J. P., Vardanian, A., Benjamin, E., Watson, M., Farmer, D. G., Ghobrial, R. M., Lipshutz, G., Yersiz, H., Lu, D. S. K., Lassman, C., et al. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e318148c704 · Cited by 445
Recurrence after liver resection for hepatocellular carcinoma: Risk factors, treatment, and outcomes
Shah, S. A., Cleary, S. P., Wei, A. C., Yang, I., Taylor, B. R., Hemming, A. W., Langer, B., Grant, D. R., Greig, P. D., & Gallinger, S. (2007) · Surgery · doi:10.1016/j.surg.2006.06.028 · Cited by 420
Busuttil, R. W., Farmer, D. G., Yersiz, H., Hiatt, J. R., McDiarmid, S. V., Goldstein, L. I., Saab, S., Han, S., Durazo, F., Weaver, M., et al. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000164077.77912.98 · Cited by 407
Large Intervening Non-Coding RNA HOTAIR is Associated with Hepatocellular Carcinoma Progression
Geng, Y., Xie, S., Li, Q., Ma, J., & Wang, G. (2011) · Journal of International Medical Research · doi:10.1177/147323001103900608 · Cited by 407
Thomas, M. B., Jaffe, D., Choti, M. M., Belghiti, J., Curley, S., Fong, Y., Gores, G., Kerlan, R., Merle, P., O'Neil, B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.7805 · Cited by 394
Self-citationRavaioli, M., Grazi, G. L., Piscaglia, F., Trevisani, F., Cescon, M., Ercolani, G., Vivarelli, M., Golfieri, R., D’Errico Grigioni, A., Panzini, I., et al. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02409.x · Cited by 363
Lee, S.-G., Hwang, S., Moon, D.-B., Ahn, C.-S., Kim, K.-H., Sung, K.-B., Ko, G.-Y., Park, K.-M., Ha, T.-Y., & Song, G.-W. (2008) · Liver Transplantation · doi:10.1002/lt.21445 · Cited by 330
Chapman, W. C., Majella Doyle, M. B., Stuart, J. E., Vachharajani, N., Crippin, J. S., Anderson, C. D., Lowell, J. A., Shenoy, S., Darcy, M. D., & Brown, D. B. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e31818a07d4 · Cited by 304
Zimmerman, M. A. (2008) · Archives of Surgery · doi:10.1001/archsurg.2007.39 · Cited by 278
Downstaging hepatocellular carcinoma: A systematic review and pooled analysis
Parikh, N. D., Waljee, A. K., & Singal, A. G. (2015) · Liver Transplantation · doi:10.1002/lt.24169 · Cited by 273
Yao, F. Y., Bass, N. M., Nikolai, B., Merriman, R., Davern, T. J., Kerlan, R., Ascher, N. L., & Roberts, J. P. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50147 · Cited by 271
Self-citationKneteman, N. M., Oberholzer, J., Al Saghier, M., Meeberg, G. A., Blitz, M., Ma, M. M., Wong, W. W. S., Gutfreund, K., Mason, A. L., Jewell, L. D., et al. (2004) · Liver Transplantation · doi:10.1002/lt.20237 · Cited by 256
Selection of patients for liver transplantation and allocation of donated livers in the UK
Neuberger, J., Gimson, A., Davies, M., Akyol, M., O’Grady, J., Burroughs, A., Hudson, M., for the Liver Advisory Group, & Transplant, U. B. A. (2008) · Gut · doi:10.1136/gut.2007.131730 · Cited by 227
Metadata
- Authors
- Yao, F. Y., Ferrell, L., Bass, N. M., Bacchetti, P., Ascher, N. L., & Roberts, J. P.
- Venue
- Liver Transplantation
- Published
- 2002-09
- Volume
- 8
- Issue
- 9
- Pages
- 765-774
- ISSN
- 1527-6465 (ISSN-L)
- OpenAlex
- W2025847972
- Cited by
- 408
- References
- 21
- FWCI
- 9.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.